Park National Corp

Roche's experimental multiple sclerosis drug fenebrutinib met its primary endpoint in a late-stage study but showed higher liver enzyme elevations and fatalities versus Ocrevus. Investors await Monday's detailed data webcast.

CleanSpark shares surged 22% to $10.08 following quarterly results showing $181.2 million in revenue and 573 bitcoin mined in January. The company highlighted its growing bitcoin holdings and expansion into AI data centers.

Major tech firms plan over $630 billion in AI data center investments for 2026, raising fears about vanishing free cash flow and potential cuts to shareholder returns. Amazon shares fell 9% after announcing a $200 billion capex plan.

Meta shares declined as the company projected 2026 capital spending could reach $135 billion, nearly double its 2025 forecast, raising investor anxiety about AI investment returns.

Silver prices rebounded sharply Friday but still posted a weekly loss exceeding 8.7% as CME Group raised margin requirements. Traders eye upcoming U.S. jobs and inflation data for direction.